Article Details

Ambrx Biopharma Inc. (NYSE: AMAM) Disappoints Wall Street With 5.33% Stock Price Gain

Retrieved on: 2022-12-19 15:00:43

Tags for this article:

Click the tags to see associated articles and topics

Ambrx Biopharma Inc. (NYSE: AMAM) Disappoints Wall Street With 5.33% Stock Price Gain. View article details on HISWAI: https://marketingsentinel.com/2022/12/19/ambrx-biopharma-inc-nyse-amam-disappoints-wall-street-with-5-33-stock-price-gain/

Excerpt

As of Jun 29, 2022, the company held 9.99% of the shares, roughly 3.86 million AMAM shares worth $10.22 million. Blackrock Inc. holds the second ...

Article found on: marketingsentinel.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up